IRVINE, Calif., March 22, 2016 -- MRI Interventions, Inc. (OTCQB:MRIC) invites investors and analysts to participate in management’s broadcast review of the Company's 2015 fourth quarter and full year results.
The conference call is scheduled to be broadcast live over the internet on Wednesday, March 23, 2016 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) and may be accessed by visiting the Company's website at www.mriinterventions.com, selecting “Investors” / “News” / “IR Calendar.” The conference call may also be accessed at http://mriinterventions.equisolvewebcast.com/q4-2015. Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-9034, or at (201) 493-6737 if calling from outside the U.S. or Canada.
For those who cannot access the live broadcast, a replay will be available shortly after the completion of the call until March 31, 2016 by calling (877) 660-6853, or (201) 612-7415 if calling from outside the U.S. or Canada, and then entering conference I.D. number 413671.
About MRI Interventions, Inc.:
Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures. The ClearPoint® System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Particular uncertainties and risks include those relating to: estimates regarding the sufficiency of the Company’s cash resources; the Company’s ability to obtain additional financing; future revenues from sales of the Company’s ClearPoint System products; and the Company’s ability to market, commercialize and achieve broader market acceptance for the Company’s ClearPoint System products. More detailed information on these and additional factors that could affect the Company's actual results are described in the "Risk Factors" sections of the Company's Form 10-K for the year ended December 31, 2014 and the Company’s Form 10-Q for the quarter ended September 30, 2015, both of which have been filed with the Securities and Exchange Commission, as well as the Company's Form 10-K for the year ended December 31, 2015, which will be filed with the Securities and Exchange Commission.
Contact: Harold A. Hurwitz, Chief Financial Officer (949) 900-6833


Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 



